Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Abpro Holdings, Inc - Common Stock
Analyst Grade Summary
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
0
0
1
0
0
No Price
01.05.2026 18:26
Current Prices from Abpro Holdings, Inc - Common Stock
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
UTC
ABPO
USD
01.05.2026 18:26
0,16 USD
-0,03 USD
-17,29 %
Share Float & Liquidity
Free Float54,11 %
Shares Float1,1 M
Shares Outstanding2,03 M
Company Profile for Abpro Holdings, Inc - Common Stock Share
Abpro Holdings, Inc., a biotechnology company, engages in developing antibody therapeutics for patients with immuno-oncology, ophthalmology, and autoimmunity issues. Its platform DiversImmune addresses a bottleneck in the antibody therapeutics industry. Its lead product candidates include ABP-100 for the treatment of breast, gastric, and colorectal cancers; and ABP-201 for the treatment of vascular diseases of the eye. The company has a strategic partnership with Abpro Bio Co. Ltd and NJCTTQ. The company was formerly known as Abpro Corporation and changed its name to Abpro Holdings, Inc. in November 2024. Abpro Holdings, Inc. was incorporated in 2004 and is headquartered in Woburn, Massachusetts.
